skip to main content
Idioma:
Refinado por: Base de dados/Biblioteca: DOAJ Directory of Open Access Journals remover Base de dados/Biblioteca: HighWire Press (Free Journals) remover Base de dados/Biblioteca: Wiley-Blackwell Open Access Collection remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Adjuvant Systemic Therapies for Resected Stages III and IV Melanoma: A Multi-Center Retrospective Clinical Study
Adjuvant Systemic Therapies for Resected Stages III and IV Melanoma: A Multi-Center Retrospective Clinical Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant Systemic Therapies for Resected Stages III and IV Melanoma: A Multi-Center Retrospective Clinical Study

Rigo, Rodrigo ; Ding, Philip Q ; Batuyong, Eugene ; Cheung, Winson Y ; Walker, John ; Monzon, Jose G ; Cheng, Tina

The oncologist (Dayton, Ohio), 2024-01, Vol.29 (1), p.57-66 [Periódico revisado por pares]

England: Oxford University Press

Texto completo disponível

Citações Citado por
2
U.S. Food and Drug Administration Approval: Peginterferon‐alfa‐2b for the Adjuvant Treatment of Patients with Melanoma
U.S. Food and Drug Administration Approval: Peginterferon‐alfa‐2b for the Adjuvant Treatment of Patients with Melanoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

U.S. Food and Drug Administration Approval: Peginterferon‐alfa‐2b for the Adjuvant Treatment of Patients with Melanoma

Herndon, Thomas M. ; Demko, Suzanne G. ; Jiang, Xiaoping ; He, Kun ; Gootenberg, Joseph E. ; Cohen, Martin H. ; Keegan, Patricia ; Pazdur, Richard

The oncologist (Dayton, Ohio), 2012-10, Vol.17 (10), p.1323-1328 [Periódico revisado por pares]

Durham, NC, USA: AlphaMed Press

Texto completo disponível

Citações Citado por
3
Retinopathy Associated with Adjuvant High‐Dose Interferon‐α2b in a Patient with Resected Melanoma: A Case Report and Review of the Literature
Retinopathy Associated with Adjuvant High‐Dose Interferon‐α2b in a Patient with Resected Melanoma: A Case Report and Review of the Literature
Material Type:
Artigo 		Adicionar ao Meu Espaço

Retinopathy Associated with Adjuvant High‐Dose Interferon‐α2b in a Patient with Resected Melanoma: A Case Report and Review of the Literature

Monzon, Jose G. ; Hammad, Nazik ; Stevens, Samuel D. ; Dancey, Janet

The oncologist (Dayton, Ohio), 2012, Vol.17 (3), p.384-387 [Periódico revisado por pares]

Durham, NC, USA: AlphaMed Press

Texto completo disponível

Citações Citado por
4
Adjuvant high-dose interferon-{alpha} for resected melanoma in a patient with HIV infection
Adjuvant high-dose interferon-{alpha} for resected melanoma in a patient with HIV infection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant high-dose interferon-{alpha} for resected melanoma in a patient with HIV infection

Saba, Nakhle S ; George, Jr, Thomas J ; Boulmay, Brian C

The oncologist (Dayton, Ohio), 2010, Vol.15 (7), p.695-698 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
5
The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer
The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

The wound inflammatory response exacerbates growth of pre-neoplastic cells and progression to cancer

Antonio, Nicole ; Bønnelykke-Behrndtz, Marie Louise ; Ward, Laura Chloe ; Collin, John ; Christensen, Ib Jarle ; Steiniche, Torben ; Schmidt, Henrik ; Feng, Yi ; Martin, Paul

The EMBO journal, 2015-09, Vol.34 (17), p.2219-2236 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
Immune checkpoint blockade can synergize with radiation therapy, even in tumors resistant to checkpoint monotherapy
Immune checkpoint blockade can synergize with radiation therapy, even in tumors resistant to checkpoint monotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immune checkpoint blockade can synergize with radiation therapy, even in tumors resistant to checkpoint monotherapy

Dörrie, Jan

EMBO molecular medicine, 2017-02, Vol.9 (2), p.135-136 [Periódico revisado por pares]

England: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
7
Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy
Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy

Ebos, John ML ; Mastri, Michalis ; Lee, Christina R ; Tracz, Amanda ; Hudson, John M ; Attwood, Kristopher ; Cruz‐Munoz, William R ; Jedeszko, Christopher ; Burns, Peter ; Kerbel, Robert S

EMBO molecular medicine, 2014-12, Vol.6 (12), p.1561-1576 [Periódico revisado por pares]

England: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
8
Staging of Regional Nodes in AJCC Stage I and II Melanoma: 18FDG PET Imaging versus Sentinel Node Detection
Staging of Regional Nodes in AJCC Stage I and II Melanoma: 18FDG PET Imaging versus Sentinel Node Detection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Staging of Regional Nodes in AJCC Stage I and II Melanoma: 18FDG PET Imaging versus Sentinel Node Detection

Belhocine, Tarik ; Pierard, Gérald ; de Labrassinne, Michel ; Lahaye, Thierry ; Rigo, Pierre

The oncologist (Dayton, Ohio), 2002, Vol.7 (4), p.271-278 [Periódico revisado por pares]

Durham, NC, USA: AlphaMed Press

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.